Findings

What do systematic reviews say?

24 questions · 25 findings · 1 reviews · Gynaecology and Fertility

No studies found 8 · 32%GRADE not reported 0 · 0%Very low 8 · 32%Low 7 · 28%Moderate 2 · 8%High 0 · 0%

Menstrual blood loss: improvement rates · women with heavy menstrual bleeding

Antifibrinolytics may leads to higher menstrual blood loss: improvement rates (overall) compared with progestogens (low certainty).

1 finding from 1 review

Antifibrinolytics for heavy menstrual bleeding 2018 · Cochrane Headline outcomes only
RR 1.54 [1.31, 1.8]
5 studies · 422 participants
Low

Adverse events (any) · women with heavy menstrual bleeding

Antifibrinolytics may leads to lower adverse events (any) compared with progestogens (low certainty).

1 finding from 1 review

Antifibrinolytics for heavy menstrual bleeding 2018 · Cochrane Headline outcomes only
RR 0.66 [0.46, 0.94]
4 studies · 349 participants
Low

Thromboembolic events · women with heavy menstrual bleeding

The review found no eligible studies for this question.

1 finding from 1 review

Antifibrinolytics for heavy menstrual bleeding 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Menstrual blood loss: mean loss · women with heavy menstrual bleeding

1 finding from 1 review

Antifibrinolytics for heavy menstrual bleeding 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 49 participants
Low